Thomas, S;
Mohammed, F;
Reijmers, RM;
Woolston, A;
Stauss, T;
Kennedy, A;
Stirling, D;
... Stauss, HJ; + view all
(2019)
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function.
Nature Communications
, 10
(1)
, Article 4451. 10.1038/s41467-019-12441-w.
Preview |
Text
Chain_Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function_VoR.pdf - Published Version Download (3MB) | Preview |
Abstract
TCR-gene-transfer is an efficient strategy to produce therapeutic T cells of defined antigen specificity. However, there are substantial variations in the cell surface expression levels of human TCRs, which can impair the function of engineered T cells. Here we demonstrate that substitutions of 3 amino acid residues in the framework of the TCR variable domains consistently increase the expression of human TCRs on the surface of engineered T cells.The modified TCRs mediate enhanced T cell proliferation, cytokine production and cytotoxicity, while reducing the peptide concentration required for triggering effector function up to 3000-fold. Adoptive transfer experiments in mice show that modified TCRs control tumor growth more efficiently than wild-type TCRs. Our data indicate that simple variable domain modifications at a distance from the antigen-binding loops lead to increased TCR expression and improved effector function. This finding provides a generic platform to optimize the efficacy of TCR gene therapy in humans.
Archive Staff Only
 |
View Item |
